<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Biogen Idec on its USD 32.5 milliontakeover of Panima Pharmaceuticals AG | Pestalozzi Attorneys at Law

Pestalozzi advised Biogen Idec on its USD 32.5 milliontakeover of Panima Pharmaceuticals AG

01.12.2010

Biogen, a Biotech company with the leading portfolio of medicines to treat multiple sclerosis (MS) aquired Swiss Biotech company Panima. Pestalozzi advised on all aspects of the transaction.

To the top

Cookies

Close
We use cookies in order to optimally design and continuously improve our website. By continuing to use the website you consent to the use of cookies. For further information about cookies please view our data protection statement.